Advancing the Science of Obesity You can make a difference. The Obesity Society connects with experts, government/non-government organizations and the public to: Develop, influence and promote vital policies and public positions Create and implement guidelines and cross-discipline learning, sharing and
The ESE Clinical Update on Management of Thyrotoxicosis 2025 will take place online from Tuesday 8 April 2025 – Thursday 10 April 2025.
Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is commonly…
In participants with heart failure with mildly reduced or preserved ejection fraction without diabetes, oral finerenone reduced the hazard of new-onset diabetes, representing a meaningful…
For the second time since 2019, the oral SGLT1 and SGLT2 dual inhibitor sotagliflozin has been denied FDA approval for adults with type 1 diabetes,…
There is no better place to share your research than ENDO, the Endocrine Society’s annual meeting. Submitting an abstract earns media coverage for your work,…
Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.
Each year, the Delbert A. Fisher Research Scholar Award provides a $2,000 honorarium to a scholar demonstrating exceptional work in the preservation of the history…
DTC as second primary malignancy was associated with increased risk for cardiovascular mortality, especially for those under 75 years of age.
For the second time since 2019, the oral SGLT1 and SGLT2 dual inhibitor sotagliflozin has been denied FDA approval for adults with type 1 diabetes,…
For more than 80 years, the Endocrine Society has recognized the achievements of endocrinologists worldwide. The Laureate Awards recognize endocrinologists for seminal research, meritorious service,…
